Collegium Pharmaceutical, Inc. (Nasdaq: COLL) announced the publication of “Oral Human Abuse Potential of Oxycodone DETERx® (Xtampza ER),” in the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE